Type: Specialist Cancer Center / Teaching Hospital
Location: London, England, United Kingdom
Founded: 1851
Affiliation: Imperial College London – Faculty of Medicine
Ownership: Public (National Health Service, NHS England)

Overview

The Royal Marsden Hospital, (RMH) is one of the world’s leading cancer centers, combining cutting-edge clinical care with pioneering research and education. As the UK’s first hospital dedicated solely to cancer treatment, RMH provides comprehensive oncology services, integrating advanced diagnostics, therapeutics, and supportive care for patients across England and internationally.

Since its founding in 1851, the hospital has evolved into a globally recognized institution. With two main sites Chelsea in central London and Sutton in southwest London Royal Marsden boasts state-of-the-art facilities designed to deliver innovative treatments, clinical trials, and multidisciplinary patient-centered care.

RMH functions as a tertiary referral center, treating complex and rare cancers, while maintaining a strategic role in shaping national cancer care standards. Its collaboration with leading research institutes ensures access to emerging therapies, precision medicine, and novel clinical trials.

Key Services & Specialties

• Medical & Clinical Oncology
• Surgical Oncology (Breast, Colorectal, Sarcoma, Head & Neck, Urology)
• Radiation Oncology & Advanced Radiotherapy Techniques
• Hematology & Bone Marrow Transplantation
• Immunotherapy & Precision Cancer Medicine
• Diagnostic Imaging (MRI, CT, PET-CT, Nuclear Medicine)
• Palliative Care & Supportive Oncology
• Clinical Trials & Experimental Therapeutics

As a nationally recognized referral center, RMH manages highly complex cancer cases, providing integrated multidisciplinary care. Cutting-edge technologies such as proton therapy, stereotactic radiotherapy, and robotic-assisted surgery ensure patients benefit from the most advanced treatment options available.

Academic & Research Role

Royal Marsden Hospital serves as a principal teaching hospital for Imperial College London, providing structured education and clinical training for:

• Undergraduate medical students
• Specialist oncology trainees and fellows
• Nursing and allied health professionals

The hospital is at the forefront of cancer research, participating in international clinical trials and translational research programs. Key focus areas include immuno-oncology, molecular pathology, early-phase clinical trials, and personalized medicine. RMH collaborates with the Institute of Cancer Research (ICR), fostering innovation that bridges laboratory discoveries with patient care.

Capacity & Facilities

• 500+ inpatient beds across Chelsea and Sutton campuses
• Specialist cancer wards and high-dependency units
• Advanced operating theatres and radiotherapy suites
• Bone marrow and stem cell transplantation units
• Comprehensive diagnostic and interventional imaging services
• Integrated digital health and electronic medical records
• Clinical trial units and research laboratories

Patient-centered design ensures comfort, privacy, and safety, supporting holistic care throughout the treatment journey. Sustainability and modern infrastructure reflect RMH’s commitment to innovation in healthcare delivery.

Mission

To provide world-class cancer care, advance oncology research, and deliver excellence in education, improving outcomes for patients with cancer locally, nationally, and globally.

Reputation

Royal Marsden Hospital is widely recognized as a benchmark institution for cancer care, research, and education. Its integration of advanced clinical services, pioneering research, and teaching excellence makes it a global leader in oncology, shaping the future of cancer treatment and patient care.